![]() |
|
|
|
|||||||||||
|
|||||||||||
|
|||||||||||
|
|||||||||||
|
![]() |
|
Mouse VCAM1 / CD106 | |
Rat | |
Mouse (tested or 100% immunogen sequence identity) | |
IgG1,k Monoclonal [M/K-2] | |
Biotin | |
Purified | |
Unmodified |
Recognizes CD106/VCAM-1 (~Mr 100kD). | |
Identification and enumeration of CD106 cells by flow cytometry. Identification of VCAM-1+ cells by immunofluorescence and immunohistochemical staining. Blockage of lymphocyte adhesion in Whitlock-Witte long-term bone marrow cultures. Inhibition of lymphopoiesis in Whitlock-Witte cultures. Immunoprecipitation. Flow Cytometry: 1 ug/1E6 cells. The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested. |
PBS, sodium azide. | |
Short term: 4°C. Long term: Store at -20°C. Avoid freeze-thaw cycles. | |
For research use only. |
VCAM1 Antibody, CD106 Antibody, CD106 antigen Antibody, INCAM-100 Antibody, V-CAM 1 Antibody, VCAM-1 Antibody
Vascular cell adhesion molecule 1, VCAM-1, is a surface glycoprotein expressed by cytokine-activated endothelium that mediates the adhesion of monocytes and lymphocytes. VCAM-1 and integrin alpha-4-beta-1 facilitate a critical cell-cell adhesion event required for survival of endothelial and mural cells during vascularization. Studies of heart development have shown that deficiencies of VCAM and in alpha-4 integrin also result in epicardial dissolution and subsequent myocardial thinning.